BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24703624)

  • 21. Activity and expression of histone acetylases and deacetylases in inflammatory phenotypes of asthma.
    Gunawardhana LP; Gibson PG; Simpson JL; Powell H; Baines KJ
    Clin Exp Allergy; 2014 Jan; 44(1):47-57. PubMed ID: 24355018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Copper induces histone hypoacetylation through directly inhibiting histone acetyltransferase activity.
    Kang J; Lin C; Chen J; Liu Q
    Chem Biol Interact; 2004 Jul; 148(3):115-23. PubMed ID: 15276868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of histone acetyltransferase and histone deacetylase activities and kinetics of histone acetylation.
    Sun JM; Spencer VA; Chen HY; Li L; Davie JR
    Methods; 2003 Sep; 31(1):12-23. PubMed ID: 12893169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Assay for inhibitory activity of histone deacetylase].
    Yoshida M
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):507-11. PubMed ID: 15114691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased histone deacetylase activity in chronic obstructive pulmonary disease.
    Ito K; Ito M; Elliott WM; Cosio B; Caramori G; Kon OM; Barczyk A; Hayashi S; Adcock IM; Hogg JC; Barnes PJ
    N Engl J Med; 2005 May; 352(19):1967-76. PubMed ID: 15888697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term intramuscular prednisolone therapy.
    WEST HF
    Ann Rheum Dis; 1962 Jun; 21(2):191-3. PubMed ID: 14006298
    [No Abstract]   [Full Text] [Related]  

  • 27. Histone Acetylation Enzymes Coordinate Metabolism and Gene Expression.
    Shen Y; Wei W; Zhou DX
    Trends Plant Sci; 2015 Oct; 20(10):614-621. PubMed ID: 26440431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adrenal roentgen therapy with cortisone-like effect].
    GREINERT
    Dtsch Gesundheitsw; 1951 Sep; 6(36):1014-15. PubMed ID: 14872671
    [No Abstract]   [Full Text] [Related]  

  • 29. [Accidents and incidents of chrysotherapy].
    MARTIN E
    Med Hyg (Geneve); 1952 Jun; 10(220):264. PubMed ID: 12992046
    [No Abstract]   [Full Text] [Related]  

  • 30. A glimpse into the future: recombinant proteins and small molecules for targeted therapies in rheumatic diseases.
    Kalden JR; Braun J
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S168-70. PubMed ID: 19822067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Implants of thyroid gland in the treatment of chronic rheumatism].
    MARTIN E; KLEPPING C; TROUBAT M; KLEPPING J; CABANNE F
    Bull Mem Soc Med Hop Paris; 1952 May 23-30; 68(18-19):589-90. PubMed ID: 14954470
    [No Abstract]   [Full Text] [Related]  

  • 32. Histone deacetylation: an important mechanism in inflammatory lung diseases.
    Adcock IM; Ito K; Barnes PJ
    COPD; 2005 Dec; 2(4):445-55. PubMed ID: 17147010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of HDAC and HAT genes in atrophying skeletal muscle.
    Beharry AW; Judge AR
    Muscle Nerve; 2015 Dec; 52(6):1098-101. PubMed ID: 26372908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species.
    Kang J; Chen J; Shi Y; Jia J; Zhang Y
    Biochem Pharmacol; 2005 Apr; 69(8):1205-13. PubMed ID: 15794941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Butazolidin in rheumatic diseases.
    GOLDFAIN E
    J Okla State Med Assoc; 1953 Feb; 46(2):27-8. PubMed ID: 13035545
    [No Abstract]   [Full Text] [Related]  

  • 36. Putting the 'HAT' back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions.
    Sleiman SF; Basso M; Mahishi L; Kozikowski AP; Donohoe ME; Langley B; Ratan RR
    Expert Opin Investig Drugs; 2009 May; 18(5):573-84. PubMed ID: 19388875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired vorinostat resistance shows partial cross-resistance to 'second-generation' HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities.
    Dedes KJ; Dedes I; Imesch P; von Bueren AO; Fink D; Fedier A
    Anticancer Drugs; 2009 Jun; 20(5):321-33. PubMed ID: 19322073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experience with cortisone in the therapy of chronic evolutive polyarthritis and ankylosing spondylarthritis; based on 100 cases treated at the Hôpital Lariboisière with a follow-up of from 6 to 18 months].
    DE SEZE S; DEBEYRE N
    Sem Hop; 1952 Sep; 28(71):2808-18. PubMed ID: 13028361
    [No Abstract]   [Full Text] [Related]  

  • 39. [The family and their role in caring for patients with rheumatoid arthritis and ankylosing spondylitis (author's transl)].
    Sitajová H; Urbánek T; Hudáková G
    Cas Lek Cesk; 1981 Apr; 120(15):447-51. PubMed ID: 7237492
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of histone acetyltransferases and histone deacetylases in adipocyte differentiation and adipogenesis.
    Zhou Y; Peng J; Jiang S
    Eur J Cell Biol; 2014 Apr; 93(4):170-7. PubMed ID: 24810880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.